Mark J. Caulfield

5 ta ish

William Harvey Research Institute

1. 2013 ESH/ESC Guidelines for the management of arterial hypertension

   Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz +89

   MaqolaOAOchiq kirish20134 iqtibos

   ABIABI:AkademIndex/2026.other.091076

2. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

   Bryan Williams, Thomas M. MacDonald, S. V. Morant +10

   MaqolaOAOchiq kirish20153 iqtibos

   ABIABI:AkademIndex/2026.other.211224

3. Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial

   Thomas M. MacDonald, Bryan Williams, David J. Webb +12

   Maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.295839

4. Genome-wide mapping of human loci for essential hypertension

   Mark J. Caulfield, Patricia B. Munroe, J Pembroke +19

   Maqola20032 iqtibos

   ABIABI:AkademIndex/2026.other.678778

5. Genetic predisposition to hypertension is associated with preeclampsia in European and Central Asian women

   Valgerður Steinthórsdóttir, Ralph McGinnis, Nicholas Williams +86

   Sharh maqolaOAOchiq kirishPregnancy and preeclampsia studiesNature Communications20200 iqtibos

   ABIABI:AkademIndex/2020.review-article.000002